Abstract

In neurodegenerative diseases, certain proteins misfold and clump in the brain. A study of mice reports that aggregated tau—a protein associated with Alzheimer’s disease—can impair the function of cells’ proteasomes, garbage disposals that cells use to break down misfolded proteins. Ramping up the activity of proteasomes with a small molecule overcame this impairment, leading to fewer tau aggregates and improved cognitive function. Natura Myeku of Columbia University and colleagues studied genetically engineered mice that express a tau protein prone to aggregate. Proteasomes isolated from these mice had less protein-dicing activity than those from normal animals. The team thinks that tau gloms on to the complex and disrupts its function. To help proteasomes overcome this disruption, the researchers turned to rolipram, a compound that triggers a pathway that phosphorylates the proteasome, a mechanism known to increase proteasome activity. When given to four- to five-month-old engineered mice, the molecule led to more

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.